Roman M. Shapiro - Concepedia

Author

Roman M. Shapiro

Dana-Farber Cancer Institute ORCID

Also Known As

Chen, Jianzhu, R Shapiro, R. Shapiro, Roman M Shapiro, Roman M. Shapiro, Roman Shapiro, Thaw Htet

125

Publications

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Brigham and Women's Hospital Harvard University Western University University of Pittsburgh

About

Roman M. Shapiro is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	301
2	Health Sciences	3	3	163
3	Arts	1	1	33
4	Language Studies	1	1	33
5	Nursing	1	1	113

Roman M. Shapiro

Publications

549

Citations

H-Index

Page 1

	Year	Citations
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer Francisco Vera-Badillo, Roman M. Shapiro, Alberto Ocaña, Annals of Oncology NursingBreast OncologyOncologyClinical EndpointClinical Trials	2013	113
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock, Blood Advances Ric TransplantHematological MalignancyTransplantationOncologyDose-escalated Venetoclax	2021	41
Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses Shaobo Yang, Michal Sheffer, Isabel E. Kaplan, Nature Biotechnology InflammationMicrobial PathogensNon-pathogenic E. ColiImmunologyImmunologic Mechanism	2024	40
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution Katie Maurer, Haesook T. Kim, Thomas M. Kuczmarski, Blood Advances	2021	37
Chinese Pidgin Russian Roman M. Shapiro Journal of Pidgin and Creole Languages Translation StudiesLanguage PolicyChatbotMultilingualismLinguistic Anthropology	2010	33
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock, Blood Advances Mixed-phenotype Acute LeukemiaTransplantation MedicineImmunologyPharmacotherapyImmunotherapy	2024	33
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience Kuo‐Kai Chin, Haesook T. Kim, Eno Inyang, Transplantation and Cellular Therapy	2021	26
CAR memory–like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer Mubin Tarannum, Khanhlinh Dinh, Juliana Vergara, Science Advances	2024	26
FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. Mark L. Jordan, Roman M. Shapiro, Carlos Vivas, PubMed	1993	24
Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast Charles M. Shapiro, David J. Schifeling, Jacob D. Bitran, Journal of Surgical Oncology Estrogen Receptor LevelsBreast OncologyEstrogen Receptor LevelIi AdenocarcinomaMedicine	1982	23

Page 1